title: Affymax poised to challenge Amgen.
authors.forename: Nuala
authors.initials: N
authors.lastname: Moran
mesh_terms: D000740:Anemia / Q000188:drug therapy*; D001709:Biotechnology / Q000379:methods / Q000639:trends*; D003132:Commerce; D000068817:Epoetin Alfa; D004920:Erythropoiesis / Q000502:physiology; D004921:Erythropoietin / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D010330:Patents as Topic; D010455:Peptides / Q000494:pharmacology; D011994:Recombinant Proteins / Q000737:chemistry; D014481:United States
chemical_list: D010455:Peptides; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa; C556270:peginesatide